Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
3M today announced positive clinical results in pivotal Phase III studies of Aldara (imiquimod) Cream, 5%, an immune response modifier (IRM), for multiple actinic keratoses (AK) and superficial...
3M Automotive Division's 3M solar reflecting film was named one of the winners of the 2003 PACE Award. The announcement was made last night (March 2) during a banquet at the Detroit Opera House....
3M Health Information Systems Division and Premier Inc. today announced a strategic agreement to market 3M's DRG Assurance consulting, assessment and documentation improvement services in...
Following today's joint announcement by Eli Lilly and Company and 3M to suspend clinical trials of resiquimod, an investigational Immune Response Modifier (IRM) compound for the treatment of...
3M announced today that 3M Innovative Properties Co. and 3M Korea, both wholly owned subsidiaries, have filed a patent infringement suit in Korean Seoul District Court seeking a preliminary...
These contacts are intended only for the media. If you are not a member of the media, please call 1-888-3M HELPS (1-888-364-3577).
We will get back to you within one business day.
Subscribe to receive automatic updates via email for 3M news & stories.